Hyperplastic polyps and colorectal cancer: is there a link?

Area of Science:

• Gastroenterology
• Oncology
• Molecular Biology

Background:

• Colorectal cancers (CRCs) are typically thought to originate from adenomatous polyps.
• Hyperplastic polyps have historically been considered benign and not associated with CRC risk.
• Current guidelines do not recommend surveillance for patients with hyperplastic polyps.

Purpose of the Study:

• To investigate the potential role of hyperplastic polyps as precursors to a specific subtype of CRC.
• To explore a novel pathway involving DNA methylation and deficient DNA mismatch repair in CRC development.
• To challenge the long-held view of hyperplastic polyps as harmless.

Main Methods:

• Review of recent evidence linking hyperplastic polyps to CRC.
• Analysis of CRC subtypes characterized by DNA methylation and genetic instability.
• Focus on the subset of hyperplastic polyps in the proximal colon.

Main Results:

• Emerging evidence suggests hyperplastic polyps may be precursors to CRC with DNA methylation.
• This pathway appears particularly relevant for proximal colon hyperplastic polyps.
• CRC is not a monolithic disease, with distinct molecular subtypes.

Conclusions:

• Hyperplastic polyps may not be harmless and could be precursors to a specific CRC subtype.
• Further research is required to elucidate the genetic steps in hyperplastic polyp-associated CRC.
• Identifying biomarkers for malignant transformation is crucial for targeted clinical screening.